Skip to content

Home

Karma Biotech is an oncology company targeting solid tumors, starting with colorectal cancer. Our technology aims to deliver cytokines and other biologicals, such as IL-15, specifically to tumor and metastatic sites, avoiding the dangers of systemic toxicity. This localized IL-15 will turn cold tumors hot, allowing the body to clear the cancer.

OUR TEAM

Karma is primed for success with a great mix of geeks and company builders

Andrew Gray, PhD

  • PhD in Immune tolerance induced by cancer
  • IndieBio alum
  • Directs Karma’s synthetic bio strategy

Alan Johnson, MBA, BS

  • Synthetic chemist with 20+ years experience
  • Iterates and validates Karma’s novel LNPs

Joe Turner

  • Previously Managing Director at Blackstone/PJT
  • MS Finance NYU
  • Leads Karma’s finance and business strategy, including commercial partnerships

Xazmin Custer, PhD

  • Metabolism & cell signaling expert

CONTACT US

Karma Biotechnologies

LOCATION

370 Amapola Avenue, Suite 101
Torrance, CA 90501

FOLLOW US ON SOCIAL MEDIA

LinkedIn
www.linkedin.com/company/karma-biotechnologies

Twitter
www.twitter.com/karmabiotech

Instagram
www.instagram.com/karmabiotech